|
|
||||||||
ORIGINAL RESEARCH |
From the Epidemic Intelligence Service, Epidemiology Program Office; and Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Address reprint requests to: Sara J. Whitehead, MD, MPH, CDC/HIV, P.O. Box 68, APO AP 96546; E-mail: swhitehead{at}cdc.gov.
OBJECTIVE: To describe characteristics and risk factors for pregnancy-related deaths due to cardiomyopathy during 19911997 and to assess reasons for the increasing trend in reporting of pregnancy-related deaths due to cardiomyopathy from 1979 through 1997.
METHODS: We used data from the Centers for Disease Control (CDC) and Preventions Pregnancy Mortality Surveillance System to examine pregnancy-related deaths due to cardiomyopathy from 1991 through 1997. The pregnancy-related mortality ratio for cardiomyopathy was defined as the number of pregnancy-related deaths from cardiomyopathy per 100,000 live births. Cardiomyopathy was classified as peripartum cardiomyopathy or cardiomyopathy due to other causes.
RESULTS: Of the 245 cardiomyopathy deaths that occurred during 19911997, 171 (70%) were due to peripartum cardiomyopathy. The cause-specific pregnancy-related mortality ratio was 0.88 per 100,000 live births. Mortality increased as maternal age increased. Black women were 6.4 times as likely to die from cardiomyopathy as white women. Among peripartum cardiomyopathy cases in which the interval from the end of pregnancy was known, 2% died undelivered, 48% died within 42 days of delivery, and 50% died between 43 days and 1 year postpartum.
CONCLUSION: Cardiomyopathy accounts for an increasing proportion of reported pregnancy-related deaths, and the more than six-fold excess risk of death from cardiomyopathy among black women is larger than that for any other cause of death. The increased reporting of these deaths might be largely due to improved case ascertainment. Further studies are required to estimate the prevalence of cardiomyopathy and identify modifiable risk factors associated with these deaths and the reasons for this racial disparity.
This article has been cited by other articles:
![]() |
M. J. Tucker, C. J. Berg, W. M. Callaghan, and J. Hsia The Black-White Disparity in Pregnancy-Related Mortality From 5 Conditions: Differences in Prevalence and Case-Fatality Rates Am J Public Health, February 1, 2007; 97(2): 247 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Berg, M. A. Harper, S. M. Atkinson, E. A. Bell, H. L. Brown, M. L. Hage, A. G. Mitra, K. J. Moise Jr, and W. M. Callaghan Preventability of Pregnancy-Related Deaths: Results of a State-Wide Review Obstet. Gynecol., December 1, 2005; 106(6): 1228 - 1234. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Fett Pregnancy-Related Mortality Due to Cardiomyopathy: United States, 1991-1997 Obstet. Gynecol., June 1, 2004; 103(6): 1342 - 1342. [Full Text] [PDF] |
||||
![]() |
Cardiomyopathy: A Growing Cause of Pregnancy-Related Death? Journal Watch Cardiology, February 20, 2004; 2004(220): 4 - 4. [Full Text] |
||||
![]() |
Cardiomyopathy: A Growing Cause of Pregnancy-Related Death? Journal Watch (General), January 27, 2004; 2004(127): 4 - 4. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |